Download VNSGU MBBS 2014 2nd Year P 4011 Pharmacology Paper 1 Question Paper

Download VNSGU ((Veer Narmad South Gujarat University)) MBBS (Bachelor of Medicine and Bachelor of Surgery) 2014 2nd Year P 4011 Pharmacology Paper 1 Previous Question Paper

0
-

0
-

0
?
-Section No. (1, 2, .. )

Nil

4p- Subject Code No. :
? LIJ
414 sai2tc-t CiALL41.1141 ICI vit 1
-
1A
4
4,41 LO.
Fillup strictly the details of 0- signs on your answer book.
Name of the Examination :
SECOND YEAR M. B. B. S.
Name of the Subject :
PHARMACOLOGY : PAPER -1
P-4011
Second Year M. B. B. S. Examination
February - 2014
Pharmacology : Paper - I
Time : Hours] [Total Marks : 40
Instructions :
(
1
)
Seat No. :
771
-
1? 1
-
17
(2) Answers must be brief, precise and to the point.
(3) Always give suitable examples wherever needed.
(4) Figures on right indicate the marks alloted to question.
1 Answer the following : (Attempt all) 9
(a) Mention the clinical status and limitations of
streptokinase.
(b) Explain the pharmacological basis of use of adrenaline
in anaphylactic shock.
(c) Explain briefly the difference between allergic and
idiosyncratic reaction.
(d) Enumerate therapeutic uses of choline esters.
(e) Define : (i) Teratogenicity (ii) Phototoxicity.
(f) Explain briefly role of mucolytics in the treatment of
cough.
(g) Explain briefly the limitations of nifedipine as an
antihypertensive agent.
(h) Write briefly about xylometazoline.
(i) Explain why beta blocker should not be combined with
verap amil.
2 Answer any three of the following : 9
(a) Describe the drug therapy of relapse of peptic ulcer.
(b) Describe the clinical uses of phenylephrine. Mention the
mode of administration for each use.
P-4011] 1 [Contd...
FirstRanker.com - FirstRanker's Choice
0
-

0
-

0
?
-Section No. (1, 2, .. )

Nil

4p- Subject Code No. :
? LIJ
414 sai2tc-t CiALL41.1141 ICI vit 1
-
1A
4
4,41 LO.
Fillup strictly the details of 0- signs on your answer book.
Name of the Examination :
SECOND YEAR M. B. B. S.
Name of the Subject :
PHARMACOLOGY : PAPER -1
P-4011
Second Year M. B. B. S. Examination
February - 2014
Pharmacology : Paper - I
Time : Hours] [Total Marks : 40
Instructions :
(
1
)
Seat No. :
771
-
1? 1
-
17
(2) Answers must be brief, precise and to the point.
(3) Always give suitable examples wherever needed.
(4) Figures on right indicate the marks alloted to question.
1 Answer the following : (Attempt all) 9
(a) Mention the clinical status and limitations of
streptokinase.
(b) Explain the pharmacological basis of use of adrenaline
in anaphylactic shock.
(c) Explain briefly the difference between allergic and
idiosyncratic reaction.
(d) Enumerate therapeutic uses of choline esters.
(e) Define : (i) Teratogenicity (ii) Phototoxicity.
(f) Explain briefly role of mucolytics in the treatment of
cough.
(g) Explain briefly the limitations of nifedipine as an
antihypertensive agent.
(h) Write briefly about xylometazoline.
(i) Explain why beta blocker should not be combined with
verap amil.
2 Answer any three of the following : 9
(a) Describe the drug therapy of relapse of peptic ulcer.
(b) Describe the clinical uses of phenylephrine. Mention the
mode of administration for each use.
P-4011] 1 [Contd...
(c) Describe the clinical uses of sodium nitroprusside.
Mention the mode of administration and precaution
required in its use.
(d) Explain mechanism of action and adverse effects of
thiazide diuretics.
3 Answer any three of the following : 12
(a) Name four drugs for emesis that act by different
mechanisms. Describe mechanism, uses and adverse
effects of each.
(b) Describe with preferred agent the clinical uses of
prostaglandin analogues.
(c) Enumerate two first generation and two second
generation antihistaminics. Describe merits and demerits
of second generation antihistaminics.
(d) Write a brief note on each of the following :
(i) Salmeterol
(ii) Iron sucrose
(iii) Warfarin
(iv) Lepirudin.
4 Answer any two of the following : 10
(a) Enumerate five commonly used drugs from different
groups for treatment of congestive cardiac failure. Justify
use of each drug for the same.
(b) Classify atropine substitutes and/or derivatives and
describe their therapeutic uses.
(c) Describe with suitable examples the pharmacokinetic
and pharmacodynamic interactions.
P -4011] 2 [400]
FirstRanker.com - FirstRanker's Choice